Business & Regulation

Biden pushed drug pricing reforms, whereas Trump is known for deregulation. What does this mean for pharma?

The career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.

To shareholders – according to an analysis of financial reports from healthcare companies.

A regulatory science push in the UK includes centres for digital transformation, AI and more.

Robert F Kennedy Jr’s recent speech suggests that investigations into childhood vaccines and over-medication could be on the cards.

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.

From gene therapy to novel excipients to trends in leadership and more. Check out some of our most popular videos.

Within two years, pharma companies may be able to rely on technology to automatically create and cross-check entire regulatory submissions.

Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.

Why you shouldn’t neglect the importance of blending people, culture, and strategy to foster success in a business.